A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

City of Hope National Medical Center, Duarte, California, United States

Ronald Regan UCLA Medical Center, Los Angeles, California, United States

University of California Irvine Health, Orange, California, United States

AdventHealth Orlando, Orlando, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Emory University Winship Cancer Institute, Atlanta, Georgia, United States

University of Illinois Medical Center - Hematology & Oncology, Chicago, Illinois, United States

University of Kansas Cancer Center-Westwood, Westwood, Kansas, United States

University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Henry Ford Cancer Institute, Detroit, Michigan, United States

Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States

Levine Cancer Institute, Charlotte, North Carolina, United States

Duke University Hospital, Durham, North Carolina, United States

Oncology Hematology Care Clinical Trials, LLC, Cincinnati, Ohio, United States

Cleveland Clinic, Cleveland, Ohio, United States

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Oregon Health and Science University, Portland, Oregon, United States

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Avera Cancer Institute, Sioux Falls, South Dakota, United States

Tristar Bone Marrow Transplant, Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

St. David's South Austin Medical Center, Austin, Texas, United States

UT Southwestern Medical Center, Dallas, Texas, United States

Intermountain Health, Salt Lake City, Utah, United States

Virginia Commonwealth University, Richmond, Virginia, United States